Dong Sung Bio Pharm.Co.,Ltd. (KOSE: A002210)
Health Care · Pharmaceuticals · KR
₩1,283.00
+0.39% today · -28.7% 1Y
Dong Sung Bio Pharm.Co.,Ltd. (KOSE: A002210) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $89.60M.
Over the last twelve months the share price has lost 28.7%, trading between 1.24K and 2.52K.
Tweenvest scores Dong Sung Bio Pharm.Co.,Ltd. across four factors: quality 71/100, value 77/100. Its strongest factor is value.
A002210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $89.60M
- Revenue (TTM)
- $67.58M
- P/E
- 13.32
- EPS
- 96.34
- Dividend yield
- —
- Beta (5Y)
- -0.40
- 52-week high
- ₩2,525.00
- 52-week low
- ₩1,239.00
- Avg volume (3M)
- —
- Shares outstanding
- 93.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rani Therapeutics Holdings, Inc.NasdaqGM: RANI | $92.22M | $0.77 | -3.65% |
| Stella Pharma CorporationTSE: 4888 | $92.15M | ¥394.00 | -7.51% |
| Shree Ganesh Remedies LimitedBSE: 540737 | $90.37M | Rs681.25 | -1.72% |
| Renascience Inc.TSE: 4889 | $89.79M | ¥1,032.00 | -6.44% |
| Neumora Therapeutics, Inc.NasdaqGS: NMRA | $89.38M | $0.45 | -5.02% |
| Dar Al Dawa Development and Investment Co. Ltd.ASE: DADI | $88.16M | JD1.25 | +1.63% |
| Hyphens Pharma International LimitedCatalist: 1J5 | $88.02M | S$0.37 | +2.82% |
| Kilitch Drugs (India) LimitedBSE: 524500 | $87.67M | Rs242.70 | +12.34% |
Figures last refreshed Oct 11, 2026.